Freedom2 Overview

  • Founded
  • 1999
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

Freedom2 General Information

Description

Developer of a permanent tattoo ink remover created to offer safe and easy future removal. The company's product uses microscopic bioabsorbable pigments and dyes that are encapsulated in a biocompatible polymer forming a microencapsulated colored bead, enabling customer to easily remove by a single standard laser treatment that breaks the polymer beads allowing the body to naturally expel the dye trapped inside.

Contact Information

Website
www.freedom2inc.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Specialty Chemicals
Acquirer
PharmaCyte Biotech
Primary Office
  • 1971 Old Cuthbert Road
  • Cherry Hill, NJ 08034
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Freedom2 Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 02-Mar-2009 00.00 Completed Generating Revenue
1. Later Stage VC (Series A) 26-Mar-2007 00.00 00.00 Completed Generating Revenue
To view Freedom2’s complete valuation and funding history, request access »

Freedom2 Patents

  • 14

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 000

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Freedom2 Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2005275173-A1 Modified tissue marking pigment and method for modifying tissue marking pigment Abandoned 15-Jul-2004 000000000
US-20080028990-A1 Modified tissue marking pigment and method for modifying tissue marking pigment Abandoned 15-Jul-2004 000000000 00
JP-2008506701-A Modified tissue marking pigment and method for modifying tissue marking pigment Pending 15-Jul-2004 000000000 0
EP-1786331-A2 Modified tissue marking pigment and method for modifying tissue marking pigment Withdrawn 15-Jul-2004 000000000
DE-69934412-D1 Tattoo ink Expired - Lifetime 18-Aug-1998 A61Q1/025
To view Freedom2’s complete patent history, request access »

Freedom2 Executive Team (7)

Name Title Board Seat Contact Info
Bruce Klitzman Ph.D Co-Founder
Kim Koger MD Co-Founder
Suzanna Mlynarczyk-Evans Ph.D Co-Founder
Martin Schmieg Chief Executive Officer
Craig Drill Co-Founder
You’re viewing 5 of 7 executive team members. Get the full list »

Freedom2 Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Hinsdale Bank & Trust Corporation Minority 000 0000 000000 0
Innovative Ventures Venture Capital Minority 000 0000 000000 0
To view Freedom2’s complete investors history, request access »

Ready to get started?

Request a free trial